Articles > New & Newsworthy

  1. 6 Themes from the 78th Annual ADA Scientific Sessions

    There were new devices, new ideas, and lots of controversy. -by Craig Idlebrook/GluCraig The 78th annual American Diabetes Association Scientific Sessions concluded this past weekend in Orlando, and a team from T1D Exchange was there to absorb the deluge of information. Using a mixture of on-the-ground-reporting and social media, we’ve compiled a list of six […]

    Read More
  2. Insulin for Life’s Hurricane Relief Effort

      T1D Exchange reached out to Dr. Mark Atkinson and Carol Atkinson, who have been working around the clock to get insulin and supplies to people affected by the hurricanes. Carol Atkinson, Director at Insulin for Life USA, speaks with T1D Exchange’s Dr. Alicia McAuliffe-Fogarty about the current needs of Insulin for Life to help […]

    Read More
  1. Medtronic Issues Urgent Device Recall Information for MiniMed Infusion Sets

    Medtronic has become aware of recent reports of potential over-delivery of insulin shortly after an infusion set change. Over-delivery of insulin can cause hypoglycemia and in extreme cases, death. Medtronic has received reports of hypoglycemia requiring medical intervention potentially related to this issue. Are your MiniMed infusion sets part of the recall? We urge you […]

    Read More
  2. It Takes an Army…and a Village

    Dear Friends, 14,000 people just spent 5 days learning to be better researchers, clinicians, scientists, and innovators in diabetes This is my fifteenth consecutive year attending the American Diabetes Association’s Scientific Sessions (the largest diabetes event in the world) where more than 14,000 global leaders meet to learn, share, and experience cutting-edge research and technology, […]

    Read More
  3. Your Questions Answered: The MiniMed 670G System

    In September, the FDA approved a big leap forward in diabetes technology, the world’s first hybrid closed loop system. The MiniMed® 670G system is designed for people with type 1 diabetes who are 14 and older.  Having been diagnosed with type 1 in 1989, when blood glucose meters were bigger than the current larger iPhone, […]

    Read More
  4. Promising Innovations in T1D Early Detection Emerge Victorious at Diabetes Innovation Challenge


      Our recent Diabetes Innovation Challenge, the first-ever, open, worldwide challenge to identify and accelerate transformational advancements in diabetes research and care, awarded Enable Biosciences the top prize in late stage development. This is the second article in our three-part series of winner profiles.  An early diagnosis is one of the most important tools available […]

    Read More